Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
8.60
+0.29 (3.49%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Avadel Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 51.37 | 31.17 | 73.98 | 50.71 | 71.72 | Upgrade
|
| Short-Term Investments | 22.41 | 73.94 | 22.52 | 106.51 | 151.16 | Upgrade
|
| Cash & Short-Term Investments | 73.78 | 105.11 | 96.5 | 157.22 | 222.88 | Upgrade
|
| Cash Growth | -29.81% | 8.92% | -38.62% | -29.46% | 247.39% | Upgrade
|
| Accounts Receivable | 34.1 | 12.1 | - | - | - | Upgrade
|
| Other Receivables | - | - | 2.25 | 31.54 | 38.44 | Upgrade
|
| Receivables | 34.1 | 12.1 | 2.25 | 31.54 | 38.44 | Upgrade
|
| Inventory | 20.3 | 10.38 | - | - | - | Upgrade
|
| Prepaid Expenses | 5.15 | 4.37 | 1.52 | 3.18 | 1.02 | Upgrade
|
| Other Current Assets | 0.88 | 2.24 | 0.57 | 0.55 | 1.12 | Upgrade
|
| Total Current Assets | 134.21 | 134.2 | 100.84 | 192.49 | 263.45 | Upgrade
|
| Property, Plant & Equipment | 12.86 | 13.08 | 13.24 | 11.49 | 8.16 | Upgrade
|
| Goodwill | 16.84 | 16.84 | 16.84 | 16.84 | 16.84 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 24.13 | 18.26 | Upgrade
|
| Other Long-Term Assets | 0.34 | 0.58 | 1.87 | 2.33 | 4.93 | Upgrade
|
| Total Assets | 164.24 | 164.7 | 132.79 | 247.27 | 311.64 | Upgrade
|
| Accounts Payable | 7.33 | 11.43 | 7.89 | 7.68 | 2.93 | Upgrade
|
| Accrued Expenses | 24.54 | 19.45 | 8.51 | 12.03 | 8.68 | Upgrade
|
| Current Portion of Long-Term Debt | 1.89 | 0.73 | 37.67 | - | - | Upgrade
|
| Current Portion of Leases | 0.58 | 0.93 | 0.96 | 0.9 | 0.47 | Upgrade
|
| Other Current Liabilities | 14.49 | 4.31 | 0.77 | 0.39 | 3.03 | Upgrade
|
| Total Current Liabilities | 48.83 | 36.86 | 55.79 | 21 | 15.11 | Upgrade
|
| Long-Term Debt | 35.25 | 32.76 | 91.61 | 142.4 | 128.21 | Upgrade
|
| Long-Term Leases | 1.12 | 1.69 | 0.78 | 1.71 | 1.84 | Upgrade
|
| Other Long-Term Liabilities | 5.18 | 5.65 | 5.74 | 3.92 | 4.21 | Upgrade
|
| Total Liabilities | 90.39 | 76.96 | 153.93 | 169.02 | 149.37 | Upgrade
|
| Common Stock | 0.97 | 0.9 | 0.63 | 0.59 | 0.58 | Upgrade
|
| Additional Paid-In Capital | 891.79 | 855.45 | 589.78 | 549.35 | 566.92 | Upgrade
|
| Retained Earnings | -794.33 | -745.5 | -585.22 | -447.76 | -384.19 | Upgrade
|
| Comprehensive Income & Other | -24.58 | -23.17 | -26.34 | -23.94 | -21.05 | Upgrade
|
| Total Common Equity | 73.85 | 87.69 | -21.15 | 78.24 | 162.26 | Upgrade
|
| Shareholders' Equity | 73.85 | 87.74 | -21.15 | 78.24 | 162.27 | Upgrade
|
| Total Liabilities & Equity | 164.24 | 164.7 | 132.79 | 247.27 | 311.64 | Upgrade
|
| Total Debt | 38.84 | 36.11 | 131.02 | 145 | 130.52 | Upgrade
|
| Net Cash (Debt) | 34.93 | 69 | -34.52 | 12.22 | 92.36 | Upgrade
|
| Net Cash Growth | -49.37% | - | - | -86.77% | - | Upgrade
|
| Net Cash Per Share | 0.37 | 0.86 | -0.57 | 0.21 | 1.68 | Upgrade
|
| Filing Date Shares Outstanding | 96.63 | 90.58 | 64.48 | 59.03 | 58.47 | Upgrade
|
| Total Common Shares Outstanding | 96.52 | 89.83 | 62.88 | 58.62 | 58.4 | Upgrade
|
| Working Capital | 85.37 | 97.35 | 45.05 | 171.49 | 248.35 | Upgrade
|
| Book Value Per Share | 0.77 | 0.98 | -0.34 | 1.33 | 2.78 | Upgrade
|
| Tangible Book Value | 57.01 | 70.85 | -37.99 | 61.4 | 145.43 | Upgrade
|
| Tangible Book Value Per Share | 0.59 | 0.79 | -0.60 | 1.05 | 2.49 | Upgrade
|
| Machinery | 0.63 | 0.63 | 0.63 | 0.3 | 0.3 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.